专利号:WO-2025118034-A1 优先权日:2023-12-06 标题 :Compounds active at the serotonergic 5-ht2a receptor 发明人:JORGENSON WILLIAM; TAN JINLONG; WHISH LACHLAN; BANISTER SAMUEL 权利人:Psylo Pty Ltd 摘要:The present disclosure relates to compounds of formula (I), their methods of synthesis, and their use in the treatment of mental illness or central nervous system disorders.
专利号:WO-2023230649-A1 优先权日:2022-05-30 标题:Compounds 发明人:BANISTER SAMUEL; JORGENSEN WILLIAM; TAN JINLONG; WHISH LACHLAN 权利人:Psylo Pty Ltd 摘要:The present disclosure relates to compounds of formula (I), their methods of synthesis, and their use in the treatment of mental illness or central nervous system disorders.
专利号:US-12415804-B2 优先权日:2023-06-28 标题 :Compounds for activating a serotonin receptor 发明人:BANISTER SAMUEL; JORGENSEN WILLIAM; TAN JINLONG; WHISH LACHLAN 权利人:Psylo Pty Ltd 摘要:The present disclosure relates generally to compounds, their methods of synthesis, and their use in the treatment of mental illness or central nervous system disorders.
专利号:US-12428380-B2 优先权日:2023-06-28 标 题 :Compounds 发明人:BANISTER SAMUEL; JORGENSEN WILLIAM; TAN JINLONG; WHISH LACHLAN 权利人:Psylo Pty Ltd 摘要:The present disclosure relates generally to compounds, their methods of synthesis, and their use in the treatment of mental illness or central nervous system disorders.
专利号:US-2025101038-A1 优先权日:2021-12-24 标 题 :Compounds 发明人:BANISTER SAMUEL; JORGENSEN WILLIAM; TAN JINLONG 权利人:Psylo Pty Ltd 摘要:The present disclosure relates generally to compounds, their methods of synthesis, and their use in the treatment of mental illness or central nervous system disorders.
专利号:US-2025163044-A1 优先权日:2021-12-24 标 题:Compounds 发明人:BANISTER SAMUEL; JORGENSEN WILLAM; TAN JINLONG 权利人:Psylo Pty Ltd 摘要:The present disclosure relates generally to compounds, their methods of synthesis, and their use in the treatment of mental illness or central nervous system disorders.
1: Caspar AT, Meyer MR, Maurer HH. Blood plasma level determination using an automated LC-MS(n) screening system and electronically stored calibrations exemplified for 22 drugs and two active metabolites often requested in emergency toxicology. Drug Test Anal. 2018 Jul 16. doi: 10.1002/dta.2466. [Epub ahead of print] doi: 10.1002/dta.2319. Epub 2017 Nov 13. doi: 10.1016/j.jpba.2017.07.011. Epub 2017 Jul 12. doi: 10.1016/j.pnpbp.2017.03.002. Epub 2017 Mar 14. Epub 2016 Aug 4. 6: Wahl M, Tipotsch-Maca SM, Vecsei-Marlovits PV. Intraoperative floppy iris syndrome and its association with various concurrent medications, bulbus length, patient age and gender. Graefes Arch Clin Exp Ophthalmol. 2017 Jan;255(1):113-118. doi: 10.1007/s00417-016-3515-7. Epub 2016 Oct 19. doi: 10.1016/j.euroneuro.2016.07.006. Epub 2016 Jul 27. doi: 10.1007/5584_2015_183. doi: 10.2116/analsci.31.961. Review. German. doi: 10.1007/s40211-014-0097-7. Epub 2014 Feb 7. German. doi: 10.1002/14651858.CD007726.pub2. Review. doi: 10.1007/s00508-013-0342-2. Epub 2013 Mar 28. Review.
合成参考文献
参考文献:10.1007/s00216-011-5187-9 摘要:Remane D, Meyer MR, Wissenbach DK, Maurer HH. Ultra high performance liquid chromatographic-tandem mass spectrometric multi-analyte procedure for target screening and quantification in human blood plasma: validation and application for 31 neuroleptics, 28 benzodiazepines, and Z-drugs. Analytical and Bioanalytical Chemistry. 2011 Jul 21;401(4):1341. doi: 10.1007/s00216-011-5187-9.